Major Medline Shareholders Offload $3.4B Stock Following IPO Rally

Key Details Medline Inc. shareholders are selling 75 million shares valued at $3.4 billion, according to a March 3 filing. Major investment firms including Blackstone, Carlyle Group, Hellman & Friedman, and Abu Dhabi Investment Authority are participating in the secondary offering. Goldman Sachs, Morgan Stanley, Bank of America, and JPMorgan Chase are arranging the sale. Why It Matters Medline's stock surged 58% since its December IPO, making it the largest U.S. public offering of the year. The share sale capitalized on this momentum, though stock prices dipped as much as 5.5% in premarket trading following the announcement. This is a significant liquidity event for the firm's founding investors. Industry Context Medline ranks No. 30 on Transport Topics' Top 100 list of North America's largest private carriers, underscoring the company's substantial logistics and distribution footprint. The offering demonstrates investor confidence in the medical supplier's market position and growth trajectory.